Fig. 5
From: Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Changes in Ragly, Raglu, GNG from glycerol, the percent of glycerol converted to glucose, rates of hepatic lipogenesis and rates of fatty acid β oxidation in skeletal muscle. Ragly (a) showed a decreasing trend after the BBR treatment. BBR dramatically decreased Raglu (b), GNG from glycerol (c) and the percent of glycerol converted to glucose (d). In addition, BBR improved hepatic lipogenesis (e) and obviously promoted fatty acid β oxidation (f). The data are expressed as the means ± SEM. *P < 0.05, NCD vs NAFLD; #P < 0.05, NAFLD vs NAFLD + BBR